Pacifico Acquisition Corp. (PAFO) Stock Analysis
DELISTED 2022
What happened to Pacifico Acquisition Corp. (PAFO) stock?
Pacifico Acquisition Corp. (PAFO) no longer trades on public markets. It was delisted in December 2022. The figures below are historical and are not a current quote.
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Pacifico Acquisition Corp. (PAFO) trades at $4.20. PAFO is a company focused on developing and marketing innovative healthcare solutions. They aim to improve patient outcomes and healthcare efficiency through their products and services. Sector: Healthcare.
Last analyzed: Mar 18, 2026Analyst Coverage for PAFO: PAFO does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates PAFO against Healthcare peers across nine fundamental dimensions and assigns a neutral fundamental signal based on the underlying data.
PAFO: the 2 scored disciplines are evenly split. Dominant signal: Seth Klarman bullish.
How is this calculated? →Pacifico Acquisition Corp. (PAFO) Healthcare & Pipeline Overview
PAFO operates in the healthcare technology sector, focusing on innovative solutions for patient care and healthcare efficiency. The company develops and markets products aimed at improving patient outcomes and streamlining healthcare processes, positioning itself as a key player in the evolving healthcare landscape.
What Is the Investment Thesis for PAFO?
PAFO presents an investment opportunity within the healthcare technology sector. The company's focus on developing innovative solutions for patient care and healthcare efficiency positions it to capitalize on the growing demand for technology-driven healthcare improvements. Key value drivers include the successful development and commercialization of new products, expansion into new markets, and strategic partnerships with healthcare providers. Upcoming catalysts include potential regulatory approvals for new products and positive clinical trial results. Potential risks include competition from established players in the healthcare technology market and the challenges of navigating the complex regulatory landscape.
Based on FMP financials and quantitative analysis
PAFO Key Highlights
Focus on innovative healthcare solutions for improved patient outcomes.
- Development and marketing of products and services aimed at enhancing healthcare efficiency.
- Potential for growth through new product launches and market expansion.
- Strategic partnerships with healthcare providers to drive adoption of PAFO's solutions.
- Commitment to addressing critical needs within the healthcare industry.
Who Are PAFO's Competitors?
PAFO is benchmarked below against 4 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| HEAL Global X - HealthTech ETF | $30.15 | +0.72% | $33.0M | 44 |
| DOCRF CloudMD Software & Services Inc. | $0.02 | -19.29% | $6.25M | 38 |
| COTV Cotiviti Holdings, Inc. | $44.74 | -0.04% | 52 | |
| HMSY HMSY | $36.98 | +0.00% | 48 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are PAFO's Key Strengths?
Innovative healthcare solutions
- Focus on patient outcomes
- Strong relationships with healthcare providers
What Are PAFO's Weaknesses?
Limited brand recognition
- Dependence on regulatory approvals
- Competition from established players
What Could Drive PAFO Stock Higher?
Potential regulatory approvals for new products.
- Positive clinical trial results.
- Expansion into new geographic markets.
- Development of new products and services.
What Are the Key Risks for PAFO?
Negative return on equity (-4.8%) — the business is not currently generating profit on shareholder capital.
- Competition from established players in the healthcare technology market.
- Challenges of navigating the complex regulatory landscape.
- Economic downturn affecting healthcare spending.
- Technological advancements by competitors.
What Are the Growth Opportunities for PAFO?
- Expansion into new geographic markets: PAFO has the opportunity to expand its geographic reach by targeting new markets where there is a demand for its healthcare technology solutions. This could involve entering new countries or regions, or expanding its presence in existing markets. The timeline for this growth opportunity is ongoing, as PAFO continuously evaluates new market opportunities. The market size for healthcare technology solutions is estimated to be billions of dollars globally, providing a significant opportunity for PAFO to increase its revenue and market share.
- Development of new products and services: PAFO can drive growth by investing in the development of new products and services that address emerging needs in the healthcare industry. This could involve developing solutions for specific medical conditions, or creating new tools for healthcare providers to improve patient care. The timeline for this growth opportunity is ongoing, as PAFO continuously innovates and develops new solutions. The market size for new healthcare technology products and services is substantial, as healthcare providers are constantly seeking new ways to improve patient outcomes and reduce costs.
- Strategic partnerships with healthcare providers: PAFO can accelerate its growth by forming strategic partnerships with healthcare providers. This could involve collaborating with hospitals, clinics, and other healthcare organizations to integrate PAFO's solutions into their existing workflows. The timeline for this growth opportunity is ongoing, as PAFO actively seeks out new partnership opportunities. The market size for partnerships between healthcare technology companies and healthcare providers is significant, as these partnerships can drive adoption of new technologies and improve patient care.
- Acquisition of complementary businesses: PAFO can expand its capabilities and market share by acquiring complementary businesses in the healthcare technology sector. This could involve acquiring companies with expertise in specific areas of healthcare, or companies with established customer relationships. The timeline for this growth opportunity is ongoing, as PAFO continuously evaluates potential acquisition targets. The market size for acquisitions in the healthcare technology sector is substantial, as companies seek to consolidate their positions and expand their offerings.
- Leveraging data analytics to improve patient outcomes: PAFO can leverage data analytics to gain insights into patient health and improve treatment outcomes. By analyzing patient data, PAFO can identify patterns and trends that can help healthcare providers make more informed decisions. The timeline for this growth opportunity is ongoing, as PAFO continuously invests in data analytics capabilities. The market size for data analytics in healthcare is significant, as healthcare providers seek to use data to improve patient care and reduce costs.
What Are PAFO's Competitive Advantages?
- Proprietary technology
- Strong relationships with healthcare providers
- Focus on innovation and addressing unmet needs
What Does PAFO Do?
PAFO is a healthcare technology company dedicated to creating and distributing innovative solutions designed to enhance patient outcomes and improve the efficiency of healthcare delivery. While specific details regarding its founding story are unavailable, PAFO has established itself as a player in the healthcare technology market by focusing on addressing critical needs within the industry. PAFO's core business revolves around developing and marketing a range of healthcare products and services. These offerings are intended to support healthcare providers in delivering better care, optimizing workflows, and reducing costs. The company's geographic reach is not specified, but it likely targets markets where there is a demand for advanced healthcare technology solutions. PAFO differentiates itself by focusing on innovation and developing solutions that meet the evolving needs of the healthcare industry. The company's products and services are designed to integrate seamlessly into existing healthcare systems, making them easy to adopt and implement.
What Products and Services Does PAFO Offer?
- Develop innovative healthcare technology solutions.
- Market products and services to healthcare providers.
- Improve patient outcomes through technology.
- Enhance healthcare efficiency and reduce costs.
- Integrate solutions into existing healthcare systems.
- Address critical needs within the healthcare industry.
How Does PAFO Make Money?
- Develop and sell healthcare technology products and services.
- Generate revenue through direct sales and partnerships.
- Invest in research and development to create new solutions.
What Industry Does PAFO Operate In?
PAFO operates within the rapidly evolving healthcare technology industry. The industry is characterized by increasing demand for innovative solutions that improve patient outcomes, enhance healthcare efficiency, and reduce costs. Key trends include the adoption of telehealth, the use of artificial intelligence in healthcare, and the growing importance of data analytics. The competitive landscape includes established players in the healthcare technology market, as well as emerging startups. PAFO aims to differentiate itself through its focus on developing solutions that meet the specific needs of healthcare providers and patients.
Who Are PAFO's Key Customers?
- Hospitals and clinics
- Healthcare providers
- Patients
Company Profile
Pacifico Acquisition Corp. operates in the Shell Companies industry within the Financial Services sector. It is headquartered in New York City, US. PAFO has traded publicly since 2021.
Key Financial Metrics
Return on equity for Pacifico Acquisition Corp. stands at -4.8%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is -0.4%, showing how much profit it generates from its asset base. A current ratio of 23.07 indicates the company holds enough short-term assets to cover its near-term obligations. Its earnings yield is -0.7%, the inverse of the P/E and a quick read on earnings relative to price.
PAFO Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis
Bull Case vs Bear Case
Bull Case
- Innovative healthcare solutions
- Focus on patient outcomes
- Strong relationships with healthcare providers
- Upcoming: Potential regulatory approvals for new products.
Bear Case
- Limited brand recognition
- Dependence on regulatory approvals
- Competition from established players
- Potential: Competition from established players in the healthcare technology market.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · August 2026
PAFO Latest News
No recent news available for PAFO.
Classification
Industry Healthcare TechnologyPAFO Healthcare Stock FAQ
What happened to Pacifico Acquisition Corp. (PAFO) stock?
Pacifico Acquisition Corp. (PAFO) no longer trades on public markets. It was delisted in December 2022. The figures below are historical and are not a current quote.
Can I still buy PAFO shares?
No. PAFO stopped trading on public markets in December 2022, so the shares are not available through a broker. Anything you see quoted for PAFO elsewhere is historical data, not a live market.
Are the figures on this page current?
No. Every number here is the last value recorded before PAFO stopped trading. Nothing on this page updates, and none of it is a current quote.
Why does this page still exist?
Because people still search for what happened to Pacifico Acquisition Corp.. An archived profile that states the delisting plainly is more useful than a dead link — provided it is labelled as history, which is what this page does.
What does PAFO do?
PAFO is a healthcare technology company that develops and markets innovative solutions designed to improve patient outcomes and enhance healthcare efficiency. The company's products and services are intended to support healthcare providers in delivering better care, optimizing workflows, and reducing costs.
What are the main risks for PAFO?
The main risks for PAFO include competition from established players in the healthcare technology market, the challenges of navigating the complex regulatory landscape, and the potential for an economic downturn affecting healthcare spending. Additionally, technological advancements by competitors could pose a threat to PAFO's market position.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Information is limited and based on available data.
- AI analysis pending for PAFO.